Francesco Casciello 46th Lorne Genome Conference 2025

Abstracts this author is presenting:

• CRISPR screens identify RNASEH2B-AS1 as a novel therapeutic target to enhance PARP inhibitor sensitivity in breast cancer — Poster Session 1